Yong Yan

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia

Shifu Xiao, Piu Chan, Tao Wang et al. · Alzheimer s Research & Therapy · 2021 · 202 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

AP39, a Mitochondria‐Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer’s Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons

Fengli Zhao, Fang Fang, Peifeng Qiao et al. · Oxidative Medicine and Cellular Longevity · 2016 · 89 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme

Shuai-Lai Wu, Xing Fu, Jinyan Huang et al. · Nucleic Acids Research · 2015 · 83 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

MicroRNA-326 Functions as a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1)

Jingxu Zhou, Tao Xu, Yong Yan et al. · PLoS ONE · 2013 · 79 citations · Full text

Medicine, Molecular Biology, Oncology +15

Baicalin improved the spatial learning ability of global ischemia/reperfusion rats by reducing hippocampal apoptosis

Oumei Cheng, Zhenhua Li, Yu Han et al. · Brain Research · 2012 · 71 citations

Life Sciences, Neuroscience, Pharmacology +16